CreatorsPublishersAdvertisers
View more in
Cancer

Dr. Robert on Evaluating Trends in Biomarker Testing in Metastatic NSCLC

onclive.com
 2021-09-09

Nicholas Robert, MD, discusses the importance of evaluating trends in biomarker testing in metastatic non–small cell lung cancer. Nicholas Robert, MD, medical director, Health Economic Outcomes Research/Health Informatics, McKesson Subspeciality Health, US Oncology, discusses

www.onclive.com

Comments / 0

Comments / 0